Management of difficult airway among patients with oropharyngeal angioedema.


Journal

The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378

Informations de publication

Date de publication:
06 2019
Historique:
accepted: 21 09 2018
pubmed: 28 12 2018
medline: 19 7 2019
entrez: 28 12 2018
Statut: ppublish

Résumé

The objective of our study was to assess the impact of a multidisciplinary difficult airway response team (DART), a quality improvement program, in the management of patients with difficult airway associated with oropharyngeal angioedema patients. Individual retrospective cohort study. Retrospective review of patient charts from July 2003 to June 2008 (pre-DART) and retrospective review of prospectively collected data from July 2008 to June 2013 (post-DART). Patients with angioedema were identified using International Classification of Disease codes 995.1 and 277.6. Patients were included in the study if an otolaryngologist was consulted for airway management. Patients were excluded if they had a history of angioedema but no active issues. Patient characteristics, airway evaluation, and interventions (intubation/surgical airway) were compared between the pre-DART and post-DART cohort. The DART team attended to 27 patients with advanced oropharyngeal angioedema. Response time averaged 3.36 minutes. Preintubation fiberoptic airway evaluations were performed in 81% of the post-DART cohort and 56% of the pre-DART cohort. The incidence of patients requiring intubation was higher in the post-DART cohort (18 out of 27 [67%]) than the pre-DART (14 out of 36 [39%]) cohort. One emergency cricothyroidotomy was performed in each of the post-DART and pre-DART cohorts. Angioedema of the larynx is a predictor of intubation or cricothyroidotomy. Fiberoptic-guided intubation is primarily used for establishing airway in angioedema patients. A multidisciplinary standardized approach such as the DART program offers adequate time and resources for airway evaluation prior to intervention and allows fewer number of attempts to secure an airway. 3 Laryngoscope, 129:1360-1367, 2019.

Identifiants

pubmed: 30588625
doi: 10.1002/lary.27622
pmc: PMC6525056
mid: NIHMS992671
doi:

Types de publication

Evaluation Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1360-1367

Subventions

Organisme : Patient-Centered Outcomes Research Institute
ID : CE-12-11-4489
Pays : United States
Organisme : NIDCD NIH HHS
ID : K23 DC014082
Pays : United States
Organisme : AHRQ HHS
ID : R01 HS024547
Pays : United States
Organisme : NIDCD NIH HHS
ID : R21 DC017225
Pays : United States

Informations de copyright

© 2018 The American Laryngological, Rhinological and Otological Society, Inc.

Références

Am J Emerg Med. 2013 Jan;31(1):124-9
pubmed: 22944544
Int Forum Allergy Rhinol. 2014 Mar;4(3):239-45
pubmed: 24415391
Am J Cardiol. 2017 Oct 15;120(8):1393-1398
pubmed: 28807405
J Surg Educ. 2018 Sep - Oct;75(5):1264-1275
pubmed: 29628333
Laryngoscope. 2011 Nov;121(11):2327-34
pubmed: 22020885
Br J Hosp Med (Lond). 2017 Mar 2;78(3):160-164
pubmed: 28277773
Int J Crit Illn Inj Sci. 2013 Apr;3(2):108-12
pubmed: 23961454
J Clin Anesth. 2016 Sep;33:273-82
pubmed: 27555177
Curr Opin Otolaryngol Head Neck Surg. 2006 Jun;14(3):170-5
pubmed: 16728895
Laryngoscope. 2011 Feb;121(2):262-6
pubmed: 21271571
Crit Care Med. 2017 Oct;45(10):1677-1682
pubmed: 28742548
Front Med (Lausanne). 2017 Dec 04;4:212
pubmed: 29255709
Anesth Analg. 2015 Jul;121(1):127-39
pubmed: 26086513
Otolaryngol Head Neck Surg. 2000 Sep;123(3):240-5
pubmed: 10964298
Laryngoscope. 2017 Apr;127(4):828-834
pubmed: 27861934
Anesthesiol Clin. 2015 Jun;33(2):369-79
pubmed: 25999009
Crit Care Med. 2013 Feb;41(2):506-17
pubmed: 23263618
Br J Hosp Med (Lond). 2017 Mar 2;78(3):143-148
pubmed: 28277768
Laryngoscope. 2015 Mar;125(3):640-4
pubmed: 25251732
Ann Otol Rhinol Laryngol. 2010 Dec;119(12):836-41
pubmed: 21250556
Eur J Emerg Med. 2016 Jun;23(3):219-23
pubmed: 25715023
Anaesthesist. 2013 Oct;62(10):832-5
pubmed: 24104949
Otolaryngol Head Neck Surg. 2015 Oct;153(4):544-50
pubmed: 26084824
Ann Otol Rhinol Laryngol. 2001 Sep;110(9):834-40
pubmed: 11558759
Br J Hosp Med (Lond). 2017 Mar 2;78(3):124-125
pubmed: 28277762
Aust N Z J Obstet Gynaecol. 2018 Feb;58(1):47-53
pubmed: 28656602
Curr Opin Anaesthesiol. 2013 Aug;26(4):481-8
pubmed: 23820104
J Clin Anesth. 2016 Jun;31:106-10
pubmed: 27185687
Scand J Trauma Resusc Emerg Med. 2017 Aug 4;25(1):77
pubmed: 28778172

Auteurs

Vinciya Pandian (V)

Johns Hopkins School of Nursing, Baltimore, Maryland.
Outcomes After Critical Illness and Surgery (OACIS) Research Group, Johns Hopkins University, Baltimore, Maryland.

Gooi Zhen (G)

University of Chicago Medicine, Chicago, Illinois, U.S.A.

Stanola Stanley (S)

Johns Hopkins School of Nursing, Baltimore, Maryland.
Outcomes After Critical Illness and Surgery (OACIS) Research Group, Johns Hopkins University, Baltimore, Maryland.

Marco Oldsman (M)

Johns Hopkins School of Nursing, Baltimore, Maryland.
Outcomes After Critical Illness and Surgery (OACIS) Research Group, Johns Hopkins University, Baltimore, Maryland.

Elliott Haut (E)

The Division of Acute Care Surgery, Department of Surgery; Department of Anesthesiology and Critical Care Medicine; Department of Emergency Medicine, Baltimore, Maryland.
The Armstrong Institute for Patient Safety and Quality, Johns Hopkins Medicine, Baltimore, Maryland.
The Department of Health Policy and Management, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Lynette Mark (L)

The Department of Anesthesiology and Critical Care Medicine, Baltimore, Maryland.

Christina Miller (C)

The Department of Anesthesiology and Critical Care Medicine, Baltimore, Maryland.

Alexander Hillel (A)

The Department of Otolaryngology Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH